Role of conventional physiotherapy in cystic fibrosis

doi:10.1016/S0022-3476(88)80370-6

The Journal of Pediatrics

Volume 113, Issue 4, October 1988, Pages 632-636

https://doi.org/10.1016/S0022-3476(88)80370-6 Get rights and content

Because of the time and the emotional cost involved in performing dally conventional chest physiotherapy in patients with cystic fibrosis, a 3-year prospective study was undertaken to compare the long-term effects of postural drainage accompanied by percussion and the forced expiratory technique with the effects of the forced expiratory technique alone. Patients who performed the forced expiratory technique alone had mean annual rates of decline that were significantly different from zero for forced expiratory volume in 1 second (p<0.001), forced expiratory flow between 25% and 75% of vital capacity (p<0.001), and Shwachman clinical score (p<0.004). In the group performing conventional physiotherapy with percussion and postural drainage, only the mean annual rate of decline for forced expiratory flow between 25% and 75% of vital capacity was significantly different from zero (p<0.03), and it was significantly different from the mean rate of decline associated with the forced expiratory technique alone (p<0.04). We conclude that conventional chest physiotherapy should remain a standard component of therapy in cystic fibrosis.

References (32)

DesmondKJ et al.
Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis
J Pediatr
(1983)
NolanG et al.
Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to cloxacillin
J Pediatr
(1982)
OrensteinDM et al.
Exercise conditioning and cardiopulmonary fitness in cystic fibrosis
Chest
(1981)
MacLuskyI et al.
LorinMI et al.
Evaluation of postural drainage by measurement of sputum volume and consistency
Am J Phys Rehabil Med
(1971)
MellinsRB
Pulmonary physiotherapy in the pediatric age group
Am Rev Respir Dis
(1974)
RochesterDF et al.
Techniques of respiratory physical therapy
Am Rev Respir Dis
(1980)
CherniackRM
Physical therapy
Am Rev Respir Dis
(1980)
JonesNL
Physical therapy: present state of the art
Am Rev Resp Dis
(1974)
MurrayJF
The ketchup-bottle method
N Engl J Med
(1979)

WongJW et al.

Effects of gravity on tracheal transport rates in normal subjects and in subjects with cystic fibrosis

Pediatrics

(1977)

MotoyamaEK

Assessment of lower airway obstruction in cystic fibrosis

FeldmanJ et al.

Maximal expiratory flows after postural drainage

Am Rev Respir Dis

(1979)

WellerPH et al.

The short-term effects of chest physiotherapy on lung function tests in children with cystic fibrosis

Respiration

(1980)

ClarkSW et al.

Effects of sputum on pulmonary function

Thorax

(1973)

CochraneGM et al.

Effects of sputum on pulmonary function

Br Med J

(1977)

Cited by (109)

Secretory hyperresponsiveness and pulmonary mucus hypersecretion
2014, Chest
Citation Excerpt :
Airway clearance can also be promoted using high-frequency chest wall compression but this is useful only in people who have an effective cough. There is some risk of mobilizing of central airway secretions patients with weakness and impaired cough.120 Although there are many high-frequency chest wall compression devices on the market, there are few long-term data evaluating their use.
The term bronchial hyperresponsiveness is generally used to describe a heightened airway smooth muscle bronchoconstrictor response measured by bronchoprovocation testing. However, the airway also responds to inflammation or bronchoprovocation with increased mucus secretion. We use the term “secretory hyperresponsiveness” to mean increased mucus secretion either intrinsically or in response to bronchoprovocation. This is not the same as retained phlegm or sputum. Unlike smooth muscle contraction, which is rapidly reversible using a bronchodilator, mucus hypersecretion produces airflow limitation that reverses more slowly and depends upon secretion clearance from the airway. Certain groups of patients appear to have greater mucus secretory response, including those with middle lobe syndrome, cough-dominant (“cough-variant”) asthma, and severe asthma. Secretory hyperresponsiveness also is a component of forms of lung cancer associated with bronchorrhea. An extreme form of secretory hyperresponsiveness may lead to plastic bronchitis, a disease characterized by rigid branching mucus casts that obstruct the airway. Secretory hyperresponsiveness and mucus hypersecretion appear to be related to activation of the extracellular-regulated kinase 1/2, signaling through the epidermal growth factor receptor, or secretory phospholipases A2. Recognizing secretory hyperresponsiveness as a distinct clinical entity may lead to more effective and targeted therapy for these diseases.
Effect of high-frequency chest wall oscillation versus chest physiotherapy on lung function after lung transplant
2014, Applied Nursing Research
Citation Excerpt :
Registered nurses performed CPT as a 3-minute treatment according to established procedure. This treatment time is consistent with the times reported in published studies, which range from 2 to 3 minutes (Kirilloff, Owens, Rogers, & Mazzocco, 1985) up to 7 to 20 minutes (Reisman et al., 1988). The treatment consisted of the following: (1) positioning the patient in a chair, leaning over a bedside table with one pillow. (
The aim of this study is to compare the effects of chest physiotherapy (CPT) and high-frequency chest wall oscillation (HFCWO) on lung function in lung transplant recipients.
Chest physiotherapy and HFCWO are routinely used after lung transplant to attenuate dyspnea, increase expiratory flow, and improve secretion clearance.
In a two-group experimental, crossover design with repeated-measures, 45 lung transplant recipients (27 single, 18 bilateral; 64% male; mean age, 57 years) were randomized to receive CPT at 10:00 AM and 2:00 PM followed by HFCWO at 6:00 PM and 10:00 PM (n = 22) or vice versa (n = 23) on postoperative day 3. Dyspnea (modified Borg score), Spo₂/FiO₂, and peak expiratory flow (PEF) were measured pre-treatment and post-treatment. Data were analyzed using chi-square tests, t tests, and linear mixed effects models.
There was no statistically significant treatment effect for dyspnea or PEF in patients who received HFCWO versus CPT. However, there was a significant treatment effect on the Spo₂/FiO₂ ratio (p < 0.0001).
Preliminary results suggest that lung function (measured by Spo₂/FiO₂) improves with HFWCO after lung transplantation. Although dyspnea and PEF did not differ significantly between treatment types, HFCWO may be an effective, feasible alternative to CPT.
Endotracheal Tube and Respiratory Care
2013, Handbook of Polymer Applications in Medicine and Medical Devices
The earliest recorded use of airway manipulation with an artificial device dates back to early Roman civilization when Asclepiades performed a tracheostomy for laryngeal edema. Today it is clear that the role of the endotracheal tube (ETT) in medicine is as invaluable as that of any other medical device created to date. The establishment of a definitive airway via the ETT in both elective and emergency situations has allowed for the delivery of immediate life-sustaining therapies during resuscitation, the maintenance of oxygenation and ventilation in prolonged illness, and the (temporary) delivery of inhaled anesthesia [1]. This chapter begins with a brief history of the development of the ETT. It describes the various ETTs available along with their indications for use and respective limitations. It reviews basic airway anatomy with regard to ETT placement, proper positioning and stabilization of the ETT, and complications attributed to its use. Finally, it addresses respiratory care of the intubated and mechanically ventilated patient.
Randomized clinical trial of mucociliary clearance techniques in non-cystic fibrosis bronchiectasis in children
2013, Fisioterapia
Evaluar la eficacia de las presiones manuales espiratorias lentas y aumentos de flujo espiratorio (AFE) combinadas con insuflación-exuflación mecánica (I-E M) y tos asistida (TA), frente al ciclo activo de técnicas respiratorias (CATR) en bronquiectasia infantil estable sin fibrosis quística (FQ).
Ensayo clínico aleatorizado en 2 grupos de 6 niños (edad 8,1 ± 1,3) que reciben 2 sesiones de fisioterapia respiratoria (FR) al mes. Las principales variables de estudio son: peso de esputo recogido tras sesión de FR y medición de la función pulmonar al inicio del estudio y a los 12 meses; capacidad vital forzada (CVF), volumen espiratorio máximo en 1 s (VEMS o FEV₁) y el flujo espiratorio forzado entre el 25%-75% de la CVF (FEF_25-75%). Asimismo, evaluamos el número de ingresos y exacerbaciones infecciosas y el impacto de la tos en la calidad de vida con el Leicester Cough Questionnaire (LCQ), al inicio y al final del estudio.
El peso del esputo y el FEF_25-75%, aumenta significativamente con las presiones manuales espiratorias lentas, AFE combinados con I-E M y TA, frente al CATR, en nuestra muestra. No hay diferencias significativas en cuanto a FEV₁ y CVF. El número de exacerbaciones disminuyó en ambos grupos con respecto al año anterior (sin tratamiento de FR), y la puntuación total del LCQ.
Las presiones manuales espiratorias lentas, AFE combinados con I-E M y TA, para la permeabilización de la vía aérea en niños con bronquiectasias sin FQ, producen beneficios significativos en comparación al CATR.
To evaluate effectiveness of manual expiratory pressure and expiratory flow increase (EFI) combined with mechanical insufflation-exsufflation (MI-E) and assisted coughing (AC) versus active cycle of breathing techniques (ACBT) in stable bronchiectasis children without cystic fibrosis (CF).
Randomized clinical trial with 2 groups of 6 children (age 8.1 ± 1.3) who received of respiratory physiotherapy (RP) sessions twice a month. The main endpoints studied are: weight of sputum collected after each session of RP and lung function measurements at baseline and 12 months, forced vital capacity (FVC), forced expiratory volume in 1 second (FEV₁), peak expiratory flow between 25%-75% of FVC (FEF_25-75%). We also evaluated the number of visits to emergency department, infective exacerbations and the impact of cough on quality of life with the Leicester Cough Questionnaire (LCQ), at the beginning and the end of study.
The weight of sputum and FEF_25-75% increase significantly with manual expiratory pressure, EFI combined with MI-E and AC versus ACBT in our sample. There are no significant differences in FEV₁ and FVC. Number of exacerbations decreased in both groups compared to the previous year (without CP treatment), and total score of the LCQ.
Slow manual expiratory pressure, EFI combined with MI-E and AC for airway permeabilization in children with non-CF bronchiectasis produce significant benefits compared to ACBT.
Endotracheal Tube and Respiratory Care
2013, Benumof and Hagberg's Airway Management
Endotracheal Tube and Respiratory Care
2012, Benumof and Hagberg's Airway Management: Third Edition

View all citing articles on Scopus

⁺: Supported in part by grant aid from the Canadian Federal Department of Health and Welfare.

View full text

Original articleRole of conventional physiotherapy in cystic fibrosis+

J Pediatr

J Pediatr

Chest

Evaluation of postural drainage by measurement of sputum volume and consistency

Am J Phys Rehabil Med

Pulmonary physiotherapy in the pediatric age group

Am Rev Respir Dis

Techniques of respiratory physical therapy

Am Rev Respir Dis

Physical therapy

Am Rev Respir Dis

Physical therapy: present state of the art

Am Rev Resp Dis

The ketchup-bottle method

N Engl J Med

Effects of gravity on tracheal transport rates in normal subjects and in subjects with cystic fibrosis

Pediatrics

Assessment of lower airway obstruction in cystic fibrosis

Maximal expiratory flows after postural drainage

Am Rev Respir Dis

The short-term effects of chest physiotherapy on lung function tests in children with cystic fibrosis

Respiration

Effects of sputum on pulmonary function

Thorax

Effects of sputum on pulmonary function

Br Med J

Original article
Role of conventional physiotherapy in cystic fibrosis+